Treatment perspectives in locally advanced unresectable pancreatic cancer
- PMID: 1760697
- DOI: 10.1002/bjs.1800781121
Treatment perspectives in locally advanced unresectable pancreatic cancer
Abstract
Locally advanced unresectable pancreatic cancer is sometimes encountered without manifest distant metastases. Twenty patients with histologically proven unresectable pancreatic cancer without distant metastases were treated with radiotherapy and 5-fluorouracil (5-FU). Radiotherapy consisted of 50 Gy external upper abdomen radiation in two courses, concomitant with intravenous 5-FU 375 mg/m2 given as a bolus injection 4-6h before radiation on the first 4 days of each treatment course. The treatment protocol was completed in 18 patients without complications. The median survival time was 10 months which compares favourably with a 3-5 months median survival time when treatment is withheld. Nine patients (45 per cent) were alive at 1 year, two patients at 2, 3 and 4 years. A second-look operation was performed in four patients 6, 11, 12 and 22 months after completion of radiotherapy. In two patients the tumour could be resected. It appears that treatment with radiotherapy and 5-FU may benefit patients with locally advanced unresectable pancreatic cancer.
Similar articles
-
Concomitant intraarterial cisplatin, intravenous 5-flourouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: a phase II study of the Puget Sound Oncology Consortium (PSOC-703).Am J Clin Oncol. 1997 Apr;20(2):161-5. doi: 10.1097/00000421-199704000-00012. Am J Clin Oncol. 1997. PMID: 9124192 Clinical Trial.
-
Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer.Am J Clin Oncol. 2001 Apr;24(2):155-9. doi: 10.1097/00000421-200104000-00012. Am J Clin Oncol. 2001. PMID: 11319291 Clinical Trial.
-
Locally advanced pancreatic cancer treated with radiation and 5-fluorouracil: a first step to neoadjuvant treatment?Dig Surg. 2005;22(3):191-7. doi: 10.1159/000087973. Epub 2005 Aug 18. Dig Surg. 2005. PMID: 16137997
-
Chemotherapy for pancreatic cancer.Baillieres Clin Gastroenterol. 1990 Dec;4(4):953-68. doi: 10.1016/0950-3528(90)90029-g. Baillieres Clin Gastroenterol. 1990. PMID: 2078794 Review.
-
Current perspectives on locally advanced pancreatic cancer.Oncology (Williston Park). 2000 Nov;14(11):1535-45; discussion 1546, 1549-52. Oncology (Williston Park). 2000. PMID: 11125940 Review.
Cited by
-
Multimodal therapies in ductal pancreatic cancer. The future.Int J Pancreatol. 1997 Feb;21(1):71-83. doi: 10.1007/BF02785923. Int J Pancreatol. 1997. PMID: 9127177 Review.
-
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.Ann Surg. 1999 Dec;230(6):776-82; discussion 782-4. doi: 10.1097/00000658-199912000-00006. Ann Surg. 1999. PMID: 10615932 Free PMC article. Clinical Trial.
-
[Therapy of pancreatic adenocarcinoma].Med Klin (Munich). 1999 Nov 15;94(11):614-25. doi: 10.1007/BF03045002. Med Klin (Munich). 1999. PMID: 10603733 Review. German.
-
Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study.Br J Cancer. 1997;75(4):597-601. doi: 10.1038/bjc.1997.104. Br J Cancer. 1997. PMID: 9052417 Free PMC article. Review.
-
Current approaches to novel therapeutics in pancreatic cancer.Invest New Drugs. 2003 Feb;21(1):113-29. doi: 10.1023/a:1022936914328. Invest New Drugs. 2003. PMID: 12795537 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical